Recent Posts
- Jeito Capital leads oversubscribed $75 million Series C in Adcendo ApS to Advance its First- and Best-in-class Clinical ADC Pipeline in Oncology
- Jeito Capital hits record $1.2 billion (€1 billion) close for Jeito II Fund to drive breakthrough therapeutic innovation for patients
- Jeito Capital appoints Samit Hirawat, M.D., as Strategic Medical Advisor to strengthen Jeito’s leadership in driving innovations for patient benefit
- Jeito Capital Makes Significant Investment in the Second Closing of Alveus Therapeutics’ Oversubscribed Series A, Bringing Total Financing to $197 Million
- Jeito Capital promotes Ksenija Pavletic to General Partner
Recent Comments